-
Signature
-
/s/ Daniel A. Boulware, Attorney-in-Fact
-
Stock symbol
-
SLQT
-
Transactions as of
-
Aug 1, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
8/3/2022, 05:19 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SLQT |
Common Stock, par value $0.01 per share |
Options Exercise |
$0 |
+562 |
+0.15% |
$0.00 |
376K |
Aug 1, 2022 |
Direct |
|
| transaction |
SLQT |
Common Stock, par value $0.01 per share |
Options Exercise |
$0 |
+940 |
+0.25% |
$0.00 |
377K |
Aug 1, 2022 |
Direct |
|
| transaction |
SLQT |
Common Stock, par value $0.01 per share |
Tax liability |
$0 |
-428 |
-0.11% |
$0.00 |
376K |
Aug 1, 2022 |
Direct |
F1 |
| holding |
SLQT |
Common Stock, par value $0.01 per share |
|
|
|
|
|
29.9K |
Aug 1, 2022 |
By Bowen Investments, LLC |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SLQT |
Restricted Stock Units |
Award |
$0 |
+30.3K |
|
$0.00 |
30.3K |
Aug 1, 2022 |
Common Stock, par value $0.01 per share |
30.3K |
|
Direct |
F3, F4, F5 |
| transaction |
SLQT |
Price-Vested Restricted Stock Units |
Award |
$0 |
+73.3K |
|
$0.00 |
73.3K |
Aug 1, 2022 |
Common Stock, par value $0.01 per share |
73.3K |
|
Direct |
F6, F7, F8 |
| transaction |
SLQT |
Restricted Stock Units |
Options Exercise |
$0 |
-562 |
-33.31% |
$0.00 |
1.13K |
Aug 1, 2022 |
Common Stock, par value $0.01 per share |
562 |
|
Direct |
F3, F4, F9 |
| transaction |
SLQT |
Restricted Stock Units |
Options Exercise |
$0 |
-940 |
-25.01% |
$0.00 |
2.82K |
Aug 1, 2022 |
Common Stock, par value $0.01 per share |
940 |
|
Direct |
F3, F4, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Customer Experience Officer; Investor Relations